ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leukapheresis Device Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-18F17292
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Leukapheresis Device Market Research Report 2024
BUY CHAPTERS

Global Leukapheresis Device Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-18F17292
Report
November 2025
Pages:161
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Asahi Kasei Medical
Haemonetics
Terumo BCT
StemCell Technologies
Fresenius
ALLCells LLC
Charles River
Precision for Medicine
Lonza
Grifols S A
Kaneka Medical

Leukapheresis Device Market

The global Leukapheresis Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Academic Research accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Leukapheresis Device leading manufacturers including Asahi Kasei Medical, Haemonetics, TERUMO BCT, STEMCELL Technologies, Fresenius, B. Braun Melsungen, AllCells, StemExpress, Charles River, Precision for Medicine, etc., dominate supply; the top five capture approximately % of global revenue, with Asahi Kasei Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Leukapheresis Device market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Leukapheresis Device Market Report

Report Metric Details
Report Name Leukapheresis Device Market
Segment by Type
  • Monoclonal Acquisition Equipment
  • Leukocyte Separation Column
  • Leukocyte Removal Filter
  • Other
Segment by Application
  • Academic Research
  • Clinical Treatment
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Asahi Kasei Medical, Haemonetics, TERUMO BCT, STEMCELL Technologies, Fresenius, B. Braun Melsungen, AllCells, StemExpress, Charles River, Precision for Medicine, Lonza, Grifols, Kaneka Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Leukapheresis Device study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Leukapheresis Device Market report?

Ans: The main players in the Leukapheresis Device Market are Asahi Kasei Medical, Haemonetics, TERUMO BCT, STEMCELL Technologies, Fresenius, B. Braun Melsungen, AllCells, StemExpress, Charles River, Precision for Medicine, Lonza, Grifols, Kaneka Medical

What are the Application segmentation covered in the Leukapheresis Device Market report?

Ans: The Applications covered in the Leukapheresis Device Market report are Academic Research, Clinical Treatment, Other

What are the Type segmentation covered in the Leukapheresis Device Market report?

Ans: The Types covered in the Leukapheresis Device Market report are Monoclonal Acquisition Equipment, Leukocyte Separation Column, Leukocyte Removal Filter, Other

1 Study Coverage
1.1 Introduction to Leukapheresis Device: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Leukapheresis Device Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Monoclonal Acquisition Equipment
1.2.3 Leukocyte Separation Column
1.2.4 Leukocyte Removal Filter
1.2.5 Other
1.3 Market Segmentation by Application
1.3.1 Global Leukapheresis Device Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Academic Research
1.3.3 Clinical Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Leukapheresis Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Leukapheresis Device Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Leukapheresis Device Sales Estimates and Forecasts 2020-2031
2.4 Global Leukapheresis Device Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Leukapheresis Device Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Leukapheresis Device Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Monoclonal Acquisition Equipment Market Size by Manufacturers
3.5.2 Leukocyte Separation Column Market Size by Manufacturers
3.5.3 Leukocyte Removal Filter Market Size by Manufacturers
3.5.4 Other Market Size by Manufacturers
3.6 Global Leukapheresis Device Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Leukapheresis Device Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Leukapheresis Device Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Leukapheresis Device Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Leukapheresis Device Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Leukapheresis Device Sales and Revenue by Type (2020-2031)
6.4 North America Leukapheresis Device Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Leukapheresis Device Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Leukapheresis Device Sales and Revenue by Type (2020-2031)
7.4 Europe Leukapheresis Device Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Leukapheresis Device Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Leukapheresis Device Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Leukapheresis Device Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Leukapheresis Device Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Leukapheresis Device Sales and Revenue by Type (2020-2031)
9.4 Central and South America Leukapheresis Device Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Leukapheresis Device Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Leukapheresis Device Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Leukapheresis Device Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Leukapheresis Device Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Asahi Kasei Medical
11.1.1 Asahi Kasei Medical Corporation Information
11.1.2 Asahi Kasei Medical Business Overview
11.1.3 Asahi Kasei Medical Leukapheresis Device Product Models, Descriptions and Specifications
11.1.4 Asahi Kasei Medical Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Asahi Kasei Medical Leukapheresis Device Sales by Product in 2024
11.1.6 Asahi Kasei Medical Leukapheresis Device Sales by Application in 2024
11.1.7 Asahi Kasei Medical Leukapheresis Device Sales by Geographic Area in 2024
11.1.8 Asahi Kasei Medical Leukapheresis Device SWOT Analysis
11.1.9 Asahi Kasei Medical Recent Developments
11.2 Haemonetics
11.2.1 Haemonetics Corporation Information
11.2.2 Haemonetics Business Overview
11.2.3 Haemonetics Leukapheresis Device Product Models, Descriptions and Specifications
11.2.4 Haemonetics Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Haemonetics Leukapheresis Device Sales by Product in 2024
11.2.6 Haemonetics Leukapheresis Device Sales by Application in 2024
11.2.7 Haemonetics Leukapheresis Device Sales by Geographic Area in 2024
11.2.8 Haemonetics Leukapheresis Device SWOT Analysis
11.2.9 Haemonetics Recent Developments
11.3 TERUMO BCT
11.3.1 TERUMO BCT Corporation Information
11.3.2 TERUMO BCT Business Overview
11.3.3 TERUMO BCT Leukapheresis Device Product Models, Descriptions and Specifications
11.3.4 TERUMO BCT Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 TERUMO BCT Leukapheresis Device Sales by Product in 2024
11.3.6 TERUMO BCT Leukapheresis Device Sales by Application in 2024
11.3.7 TERUMO BCT Leukapheresis Device Sales by Geographic Area in 2024
11.3.8 TERUMO BCT Leukapheresis Device SWOT Analysis
11.3.9 TERUMO BCT Recent Developments
11.4 STEMCELL Technologies
11.4.1 STEMCELL Technologies Corporation Information
11.4.2 STEMCELL Technologies Business Overview
11.4.3 STEMCELL Technologies Leukapheresis Device Product Models, Descriptions and Specifications
11.4.4 STEMCELL Technologies Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 STEMCELL Technologies Leukapheresis Device Sales by Product in 2024
11.4.6 STEMCELL Technologies Leukapheresis Device Sales by Application in 2024
11.4.7 STEMCELL Technologies Leukapheresis Device Sales by Geographic Area in 2024
11.4.8 STEMCELL Technologies Leukapheresis Device SWOT Analysis
11.4.9 STEMCELL Technologies Recent Developments
11.5 Fresenius
11.5.1 Fresenius Corporation Information
11.5.2 Fresenius Business Overview
11.5.3 Fresenius Leukapheresis Device Product Models, Descriptions and Specifications
11.5.4 Fresenius Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Fresenius Leukapheresis Device Sales by Product in 2024
11.5.6 Fresenius Leukapheresis Device Sales by Application in 2024
11.5.7 Fresenius Leukapheresis Device Sales by Geographic Area in 2024
11.5.8 Fresenius Leukapheresis Device SWOT Analysis
11.5.9 Fresenius Recent Developments
11.6 B. Braun Melsungen
11.6.1 B. Braun Melsungen Corporation Information
11.6.2 B. Braun Melsungen Business Overview
11.6.3 B. Braun Melsungen Leukapheresis Device Product Models, Descriptions and Specifications
11.6.4 B. Braun Melsungen Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 B. Braun Melsungen Recent Developments
11.7 AllCells
11.7.1 AllCells Corporation Information
11.7.2 AllCells Business Overview
11.7.3 AllCells Leukapheresis Device Product Models, Descriptions and Specifications
11.7.4 AllCells Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 AllCells Recent Developments
11.8 StemExpress
11.8.1 StemExpress Corporation Information
11.8.2 StemExpress Business Overview
11.8.3 StemExpress Leukapheresis Device Product Models, Descriptions and Specifications
11.8.4 StemExpress Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 StemExpress Recent Developments
11.9 Charles River
11.9.1 Charles River Corporation Information
11.9.2 Charles River Business Overview
11.9.3 Charles River Leukapheresis Device Product Models, Descriptions and Specifications
11.9.4 Charles River Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Charles River Recent Developments
11.10 Precision for Medicine
11.10.1 Precision for Medicine Corporation Information
11.10.2 Precision for Medicine Business Overview
11.10.3 Precision for Medicine Leukapheresis Device Product Models, Descriptions and Specifications
11.10.4 Precision for Medicine Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Precision for Medicine Recent Developments
11.11 Lonza
11.11.1 Lonza Corporation Information
11.11.2 Lonza Business Overview
11.11.3 Lonza Leukapheresis Device Product Models, Descriptions and Specifications
11.11.4 Lonza Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Lonza Recent Developments
11.12 Grifols
11.12.1 Grifols Corporation Information
11.12.2 Grifols Business Overview
11.12.3 Grifols Leukapheresis Device Product Models, Descriptions and Specifications
11.12.4 Grifols Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Grifols Recent Developments
11.13 Kaneka Medical
11.13.1 Kaneka Medical Corporation Information
11.13.2 Kaneka Medical Business Overview
11.13.3 Kaneka Medical Leukapheresis Device Product Models, Descriptions and Specifications
11.13.4 Kaneka Medical Leukapheresis Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Kaneka Medical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Leukapheresis Device Industry Chain
12.2 Leukapheresis Device Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Leukapheresis Device Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Leukapheresis Device Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Leukapheresis Device Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Leukapheresis Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Asahi Kasei Medical
Haemonetics
Terumo BCT
StemCell Technologies
Fresenius
ALLCells LLC
Charles River
Precision for Medicine
Lonza
Grifols S A
Kaneka Medical
List of Tables
 Table 1. Global Leukapheresis Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Leukapheresis Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Leukapheresis Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Leukapheresis Device Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Leukapheresis Device Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Leukapheresis Device Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Leukapheresis Device Sales by Region (2020-2025) & (K Units)
 Table 8. Global Leukapheresis Device Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Leukapheresis Device Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Leukapheresis Device Sales Share by Manufacturers (2020-2025)
 Table 12. Global Leukapheresis Device Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Leukapheresis Device Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Leukapheresis Device by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leukapheresis Device as of 2024)
 Table 16. Global Leukapheresis Device Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Leukapheresis Device Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Leukapheresis Device Manufacturing Base and Headquarters
 Table 19. Global Leukapheresis Device Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Leukapheresis Device Sales by Type (2020-2025) & (K Units)
 Table 23. Global Leukapheresis Device Sales by Type (2026-2031) & (K Units)
 Table 24. Global Leukapheresis Device Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Leukapheresis Device Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Leukapheresis Device ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Leukapheresis Device Sales by Application (2020-2025) & (K Units)
 Table 29. Global Leukapheresis Device Sales by Application (2026-2031) & (K Units)
 Table 30. Leukapheresis Device High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Leukapheresis Device Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Leukapheresis Device Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Leukapheresis Device ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Leukapheresis Device Growth Accelerators and Market Barriers
 Table 37. North America Leukapheresis Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Leukapheresis Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Leukapheresis Device Growth Accelerators and Market Barriers
 Table 40. Europe Leukapheresis Device Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Leukapheresis Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Leukapheresis Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Leukapheresis Device Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Leukapheresis Device Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Leukapheresis Device Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Leukapheresis Device Investment Opportunities and Key Challenges
 Table 47. Central and South America Leukapheresis Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Leukapheresis Device Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Leukapheresis Device Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Asahi Kasei Medical Corporation Information
 Table 51. Asahi Kasei Medical Description and Major Businesses
 Table 52. Asahi Kasei Medical Product Models, Descriptions and Specifications
 Table 53. Asahi Kasei Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Asahi Kasei Medical Sales Value Proportion by Product in 2024
 Table 55. Asahi Kasei Medical Sales Value Proportion by Application in 2024
 Table 56. Asahi Kasei Medical Sales Value Proportion by Geographic Area in 2024
 Table 57. Asahi Kasei Medical Leukapheresis Device SWOT Analysis
 Table 58. Asahi Kasei Medical Recent Developments
 Table 59. Haemonetics Corporation Information
 Table 60. Haemonetics Description and Major Businesses
 Table 61. Haemonetics Product Models, Descriptions and Specifications
 Table 62. Haemonetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Haemonetics Sales Value Proportion by Product in 2024
 Table 64. Haemonetics Sales Value Proportion by Application in 2024
 Table 65. Haemonetics Sales Value Proportion by Geographic Area in 2024
 Table 66. Haemonetics Leukapheresis Device SWOT Analysis
 Table 67. Haemonetics Recent Developments
 Table 68. TERUMO BCT Corporation Information
 Table 69. TERUMO BCT Description and Major Businesses
 Table 70. TERUMO BCT Product Models, Descriptions and Specifications
 Table 71. TERUMO BCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. TERUMO BCT Sales Value Proportion by Product in 2024
 Table 73. TERUMO BCT Sales Value Proportion by Application in 2024
 Table 74. TERUMO BCT Sales Value Proportion by Geographic Area in 2024
 Table 75. TERUMO BCT Leukapheresis Device SWOT Analysis
 Table 76. TERUMO BCT Recent Developments
 Table 77. STEMCELL Technologies Corporation Information
 Table 78. STEMCELL Technologies Description and Major Businesses
 Table 79. STEMCELL Technologies Product Models, Descriptions and Specifications
 Table 80. STEMCELL Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. STEMCELL Technologies Sales Value Proportion by Product in 2024
 Table 82. STEMCELL Technologies Sales Value Proportion by Application in 2024
 Table 83. STEMCELL Technologies Sales Value Proportion by Geographic Area in 2024
 Table 84. STEMCELL Technologies Leukapheresis Device SWOT Analysis
 Table 85. STEMCELL Technologies Recent Developments
 Table 86. Fresenius Corporation Information
 Table 87. Fresenius Description and Major Businesses
 Table 88. Fresenius Product Models, Descriptions and Specifications
 Table 89. Fresenius Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Fresenius Sales Value Proportion by Product in 2024
 Table 91. Fresenius Sales Value Proportion by Application in 2024
 Table 92. Fresenius Sales Value Proportion by Geographic Area in 2024
 Table 93. Fresenius Leukapheresis Device SWOT Analysis
 Table 94. Fresenius Recent Developments
 Table 95. B. Braun Melsungen Corporation Information
 Table 96. B. Braun Melsungen Description and Major Businesses
 Table 97. B. Braun Melsungen Product Models, Descriptions and Specifications
 Table 98. B. Braun Melsungen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. B. Braun Melsungen Recent Developments
 Table 100. AllCells Corporation Information
 Table 101. AllCells Description and Major Businesses
 Table 102. AllCells Product Models, Descriptions and Specifications
 Table 103. AllCells Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. AllCells Recent Developments
 Table 105. StemExpress Corporation Information
 Table 106. StemExpress Description and Major Businesses
 Table 107. StemExpress Product Models, Descriptions and Specifications
 Table 108. StemExpress Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. StemExpress Recent Developments
 Table 110. Charles River Corporation Information
 Table 111. Charles River Description and Major Businesses
 Table 112. Charles River Product Models, Descriptions and Specifications
 Table 113. Charles River Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Charles River Recent Developments
 Table 115. Precision for Medicine Corporation Information
 Table 116. Precision for Medicine Description and Major Businesses
 Table 117. Precision for Medicine Product Models, Descriptions and Specifications
 Table 118. Precision for Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Precision for Medicine Recent Developments
 Table 120. Lonza Corporation Information
 Table 121. Lonza Description and Major Businesses
 Table 122. Lonza Product Models, Descriptions and Specifications
 Table 123. Lonza Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Lonza Recent Developments
 Table 125. Grifols Corporation Information
 Table 126. Grifols Description and Major Businesses
 Table 127. Grifols Product Models, Descriptions and Specifications
 Table 128. Grifols Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Grifols Recent Developments
 Table 130. Kaneka Medical Corporation Information
 Table 131. Kaneka Medical Description and Major Businesses
 Table 132. Kaneka Medical Product Models, Descriptions and Specifications
 Table 133. Kaneka Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Kaneka Medical Recent Developments
 Table 135. Key Raw Materials Distribution
 Table 136. Raw Materials Key Suppliers
 Table 137. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 138. Milestones in Production Technology Evolution
 Table 139. Distributors List
 Table 140. Market Trends and Market Evolution
 Table 141. Market Drivers and Opportunities
 Table 142. Market Challenges, Risks, and Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources


List of Figures
 Figure 1. Leukapheresis Device Product Picture
 Figure 2. Global Leukapheresis Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Monoclonal Acquisition Equipment Product Picture
 Figure 4. Leukocyte Separation Column Product Picture
 Figure 5. Leukocyte Removal Filter Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Leukapheresis Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Academic Research
 Figure 9. Clinical Treatment
 Figure 10. Other
 Figure 11. Leukapheresis Device Report Years Considered
 Figure 12. Global Leukapheresis Device Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Leukapheresis Device Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Leukapheresis Device Revenue Market Share by Region (2020-2031)
 Figure 16. Global Leukapheresis Device Sales (2020-2031) & (K Units)
 Figure 17. Global Leukapheresis Device Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 18. Global Leukapheresis Device Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Leukapheresis Device Sales Volume Market Share in 2024
 Figure 20. Global Leukapheresis Device Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Monoclonal Acquisition Equipment Revenue Market Share by Manufacturer in 2024
 Figure 23. Leukocyte Separation Column Revenue Market Share by Manufacturer in 2024
 Figure 24. Leukocyte Removal Filter Revenue Market Share by Manufacturer in 2024
 Figure 25. Other Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Leukapheresis Device Sales Market Share by Type (2020-2031)
 Figure 27. Global Leukapheresis Device Revenue Market Share by Type (2020-2031)
 Figure 28. Global Leukapheresis Device Sales Market Share by Application (2020-2031)
 Figure 29. Global Leukapheresis Device Revenue Market Share by Application (2020-2031)
 Figure 30. North America Leukapheresis Device Sales YoY (2020-2031) & (K Units)
 Figure 31. North America Leukapheresis Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Leukapheresis Device Sales Revenue (US$ Million) in 2024
 Figure 33. North America Leukapheresis Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 34. North America Leukapheresis Device Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Leukapheresis Device Sales Volume (K Units) by Application (2020-2031)
 Figure 36. North America Leukapheresis Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Leukapheresis Device Sales YoY (2020-2031) & (K Units)
 Figure 41. Europe Leukapheresis Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Leukapheresis Device Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Leukapheresis Device Sales Volume (K Units) by Type (2020-2031)
 Figure 44. Europe Leukapheresis Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Leukapheresis Device Sales Volume (K Units) by Application (2020-2031)
 Figure 46. Europe Leukapheresis Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 48. France Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Leukapheresis Device Sales YoY (2020-2031) & (K Units)
 Figure 53. Asia-Pacific Leukapheresis Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Leukapheresis Device Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Leukapheresis Device Sales Volume (K Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific Leukapheresis Device Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Leukapheresis Device Sales Volume (K Units) by Application (2020-2031)
 Figure 58. Asia-Pacific Leukapheresis Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 63. India Leukapheresis Device Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Leukapheresis Device Sales YoY (2020-2031) & (K Units)
 Figure 65. Central and South America Leukapheresis Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Leukapheresis Device Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Leukapheresis Device Sales Volume (K Units) by Type (2021-2031)
 Figure 68. Central and South America Leukapheresis Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Leukapheresis Device Sales Volume (K Units) by Application (2020-2031)
 Figure 70. Central and South America Leukapheresis Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Leukapheresis Device Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Leukapheresis Device Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Leukapheresis Device Sales YoY (2020-2031) & (K Units)
 Figure 74. Middle East and Africa Leukapheresis Device Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Leukapheresis Device Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Leukapheresis Device Sales Volume (K Units) by Type (2021-2031)
 Figure 77. South America Leukapheresis Device Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Leukapheresis Device Sales Volume (K Units) by Application (2020-2031)
 Figure 79. Middle East and Africa Leukapheresis Device Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Leukapheresis Device Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Leukapheresis Device Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Leukapheresis Device Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Leukapheresis Device Revenue (2020-2025) & (US$ Million)
 Figure 84. Leukapheresis Device Industry Chain Mapping
 Figure 85. Regional Leukapheresis Device Manufacturing Base Distribution (%)
 Figure 86. Global Leukapheresis Device Production Market Share by Region (2020-2031)
 Figure 87. Leukapheresis Device Production Process
 Figure 88. Regional Leukapheresis Device Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Leukapheresis Products Market Research Report 2024
Global Plasmapheresis Membrane and Device Market Research Report 2024
Global Plasmapheresis Systems Market Research Report 2025
Global Photopheresis Market Research Report 2024
Global Continuous Flow Apheresis Device Market Research Report 2025
Global Blood Purification Devices and Consumables Market Research Report 2024
Blood Processing Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Extracorporeal Blood Purification Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Continuous Blood Purification Equipment Market Research Report 2024
Global Disposable Leukocyte Removal Filter Market Research Report 2024
Global Dialysis Device And Concentrates Market Research Report 2025
Global Medical Blood Purification Equipment Market Research Report 2024
Medical Plasmapheresis Filters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Haematology Analyser Market Research Report 2024
Acute Blood Purification Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Low density Lipoprotein Apheresis Therapy Market Research Report 2024
Global Water Purification Equipment for Dialysis Market Research Report 2025
Global Blood Purification Consumable Market Research Report 2024
Blood Apheresis Collection Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasmapheresis Filters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions